340B Drug Pricing Program
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and…
he AHA today submitted comments on the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
AHA comments on the bipartisan leadership in introducing the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
The AHA Sept. 23 submitted comments on the Strengthening the Exercise of Controls and Upgrading Requirements for Efficiency in 340B Act (SECURE 340B Act).
The AHA today told the CMS that a proposal included in the agency’s calendar year 2027 physician fee schedule proposed rule to make reporting mandatory as of Jan. 1, 2027, significantly understates the time, resources and complexity required for hospitals to comply.
A side-by-side comparison of each proposal and how each bill would address key program components.
As policymakers continue to discuss healthcare legislation, the AHA has developed several new resources to help hospitals and other stakeholders understand the proposals and their potential impact.
The Health Resources and Services Administration’s Office of Pharmacy Affairs Sept. 8 released information on the 340B Office of Pharmacy Affairs Information System Paperwork Reduction Act forms.
Several states have enacted laws protecting 340B contract pharmacy arrangements by requiring drug manufacturers to honor discounted pricing at those locations to preserve patient access. Manufacturers have challenged these laws in courts nationwide. This webpage compiles decisions in those cases as…
The Centers for Medicare & Medicaid Services has released a fact sheet and FAQs on the 340B Part D claims data repository that will go live Oct. 1.